Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pharmacol Exp Ther ; 2024 Jun 12.
Artigo em Inglês | MEDLINE | ID: mdl-38866563

RESUMO

Mutations in the GNAO1 gene, which encodes the abundant brain G-protein Gαo, result in neurologic disorders characterized by developmental delay, epilepsy, and movement abnormalities. There are over 50 mutant alleles associated with GNAO1 disorders; the R209H mutation results in dystonia, choreoathetosis, and developmental delay without seizures. Mice heterozygous for the human mutant allele (Gnao1 +/R209H) exhibit hyperactivity in open field tests but no seizures. We developed self-complimentary adeno-associated virus vectors (scAAV9) expressing two splice variants of human GNAO1 Gαo isoforms 1 (GoA, GNAO1.1) and 2 (GoB, GNAO1.2). Bilateral intra-striatal injections of either scAAV9-GNAO1.1 or scAAV9-GNAO1.2 significantly reversed mutation-associated hyperactivity in open field tests. GNAO1 overexpression did not increase seizure susceptibility, a potential side-effect of GNAO1 vector treatment. This represents the first report of successful preclinical gene therapy for GNAO1 encephalopathy applied in vivo Further studies are needed to uncover the molecular mechanism that results in behavior improvements after scAAV9-mediated Gαo expression and to refine the vector design. Significance Statement GNAO1 mutations cause a spectrum of developmental, epilepsy, and movement disorders. Here, we show that intra-striatal delivery of scAAV9-GNAO1 to express the wild-type Gαo protein reduces the hyperactivity of the Gnao1 +/R209H mouse model, which carries one of the most common movement disorder-associated mutations. This is the first report of a gene therapy for GNAO1 encephalopathy applied in vivo on a patient-allele model.

2.
J Neurophysiol ; 127(3): 607-622, 2022 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-35080448

RESUMO

GNAO1 encodes Gαo, a heterotrimeric G protein α subunit in the Gi/o family. In this report, we used a Gnao1 mouse model "G203R" previously described as a "gain-of-function" Gnao1 mutant with movement abnormalities and enhanced seizure susceptibility. Here, we report an unexpected second mutation resulting in a loss-of-function Gαo protein, and describe alterations in central synaptic transmission. Whole cell patch clamp recordings from Purkinje cells (PCs) in acute cerebellar slices from Gnao1 mutant mice showed significantly lower frequencies of spontaneous and miniature inhibitory postsynaptic currents (sIPSCs and mIPSCs) compared with WT mice. There was no significant change in sEPSCs or mEPSCs. Whereas mIPSC frequency was reduced, mIPSC amplitudes were not affected, suggesting a presynaptic mechanism of action. A modest decrease in the number of molecular layer interneurons was insufficient to explain the magnitude of IPSC suppression. Paradoxically, Gi/o inhibitors (pertussis toxin) enhanced the mutant-suppressed mIPSC frequency and eliminated the difference between WT and Gnao1 mice. Although GABAB receptor regulates mIPSCs, neither agonists nor antagonists of this receptor altered function in the mutant mouse PCs. This study is an electrophysiological investigation of the role of Gi/o protein in cerebellar synaptic transmission using an animal model with a loss-of-function Gi/o protein.NEW & NOTEWORTHY This report reveals the electrophysiological mechanisms of a movement disorder animal model with monoallelic Gnao1 loss. This study illustrates the role of Gαo protein in regulating GABA release in mouse cerebellum. This study could also facilitate the discovery of new drugs or drug repurposing for GNAO1-associated disorders. Moreover, since GNAO1 shares pathways with other genes related to movement disorders, developing drugs for the treatment of GNAO1-associated movement disorders could further the pharmacological intervention for other monogenic movement disorders.


Assuntos
Transtornos dos Movimentos , Células de Purkinje , Animais , Cerebelo/fisiologia , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/genética , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/metabolismo , Camundongos , Células de Purkinje/fisiologia , Transmissão Sináptica/fisiologia , Ácido gama-Aminobutírico/metabolismo
3.
Philos Trans A Math Phys Eng Sci ; 372(2030)2014 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-25368345

RESUMO

Surface sediments at Lakes Fryxell, Vanda and Brownworth in the Antarctic Dry Valleys (ADV) were investigated as analogues for the cold, dry environment on Mars. Sediments were sampled from regions surrounding the lakes and from the ice cover on top of the lakes. The ADV sediments were studied using Raman spectra of individual grains and reflectance spectra of bulk particulate samples and compared with previous analyses of subsurface and lakebottom sediments. Elemental abundances were coordinated with the spectral data in order to assess trends in sediment alteration. The surface sediments in this study were compared with lakebottom sediments (Bishop JL et al. 2003 Int. J. Astrobiol. 2, 273-287 (doi:10.1017/S1473550403001654)) and samples from soil pits (Englert P et al. 2013 In European Planetary Science Congress, abstract no. 96; Englert P et al. 2014 In 45th Lunar and Planetary Science Conf., abstract no. 1707). Feldspar, quartz and pyroxene are common minerals found in all the sediments. Minor abundances of carbonate, chlorite, actinolite and allophane are also found in the surface sediments, and are similar to minerals found in greater abundance in the lakebottom sediments. Surface sediment formation is dominated by physical processes; a few centimetres below the surface chemical alteration sets in, whereas lakebottom sediments experience biomineralization. Characterizing the mineralogical variations in these samples provides insights into the alteration processes occurring in the ADV and supports understanding alteration in the cold and dry environment on Mars.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA